Peter Bill Juul Ladegaard
Papers
1
Total Citations
32
H-Index
1
About
Peter Bill Juul Ladegaard is a leading clinical researcher in urology, with a focused expertise in erectile dysfunction (ED) and post-surgical penile rehabilitation. His work centers on evaluating innovative, non-invasive treatments to improve patient outcomes following radical prostatectomy. Ladegaard’s most significant contribution is his landmark 2021 prospective, randomized, placebo-controlled trial investigating low-intensity extracorporeal shockwave therapy (LI-ESWT) for men with ED after robotic prostatectomy. This study, which has garnered 32 citations, provided rigorous evidence challenging earlier, less controlled claims, demonstrating that LI-ESWT did not significantly improve erectile function compared to placebo in this specific patient population. By conducting a high-quality, sham-controlled trial, Ladegaard has helped clarify the true efficacy of shockwave therapy, saving patients from ineffective treatments and guiding future research toward more promising avenues. His work is essential reading for urologists and researchers seeking evidence-based approaches to post-prostatectomy sexual health, marking him as a rigorous and impactful voice in the field of men’s health.
Research Focus
Key Achievements
Top Papers
- 1